We are live on
!
Find out more
HCM
Howland Capital Management Portfolio holdings
AUM
$2.77B
1-Year Est. Return
19.56%
This Fund
S&P 500
This Quarter
Est. Return
+0.33%
1 Year Est. Return
+19.56%
3 Year Est. Return
+72.01%
5 Year Est. Return
+82.45%
10 Year Est. Return
+296.19%
AUM
$633M
AUM Growth
–
Cap. Flow
+$652M
Cap. Flow
% of AUM
102.99%
Top 10 Holdings %
Top 10 Hldgs %
23.96%
Holding
136
New
136
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$23M |
| 2 |
ExxonMobil
XOM
|
+$20M |
| 3 |
GE Aerospace
GE
|
+$19.8M |
| 4 |
Microsoft
MSFT
|
+$16.2M |
| 5 |
Gilead Sciences
GILD
|
+$15.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.4% |
| 2 | Technology | 11.82% |
| 3 | Industrials | 11.15% |
| 4 | Energy | 9.78% |
| 5 | Financials | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ExxonMobil
XOM
$651B
| $20.1M | 3.18% |
+222,440
| New | +$20M |
|
|
2
GE Aerospace
GE
$367B
| $19.9M | 3.14% |
+178,653
| New | +$19.8M |
|
|
3
Microsoft
MSFT
$2.84T
| $17.1M | 2.69% |
+493,653
| New | +$16.2M |
|
|
4
Gilead Sciences
GILD
$161B
| $15.4M | 2.44% |
+300,907
| New | +$15.7M |
|
5
UGI
UGI
$8B
| $14.5M | 2.29% |
+556,472
| New | +$14.6M |
|
6
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $14M | 2.21% |
+174,366
| New | +$14.1M |
|
7
Danaher
DHR
$135B
| $12.9M | 2.05% |
+304,169
| New | +$12.6M |
|
8
Chubb
CB
$140B
| $12.8M | 2.03% |
+143,565
| New | +$12.9M |
|
9
Procter & Gamble
PG
$343B
| $12.5M | 1.97% |
+162,317
| New | +$12.7M |
|
10
Core Laboratories
CLB
$538M
| $12.4M | 1.96% |
+81,979
| New | +$11.6M |
|
11
Healthpeak Properties
DOC
$15.4B
| $12.3M | 1.95% |
+297,682
| New | +$13.6M |
|
12
Johnson & Johnson
JNJ
$635B
| $12.2M | 1.92% |
+141,577
| New | +$12M |
|
13
Chevron
CVX
$388B
| $11.4M | 1.8% |
+96,102
| New | +$11.6M |
|
14
Qualcomm
QCOM
$176B
| $11.4M | 1.79% |
+185,891
| New | +$11.9M |
|
|
WBA
15
DELISTED
Walgreens Boots Alliance
WBA
| $11.3M | 1.79% |
+256,777
| New | +$12.5M |
|
16
PepsiCo
PEP
$186B
| $11.2M | 1.77% |
+137,034
| New | +$11.2M |
|
17
United Parcel Service
UPS
$97.6B
| $11.2M | 1.77% |
+129,418
| New | +$11.1M |
|
18
Colgate-Palmolive
CL
$72.6B
| $10.5M | 1.65% |
+182,515
| New | +$10.8M |
|
19
Visa
V
$677B
| $10.2M | 1.62% |
+223,868
| New | +$9.8M |
|
20
Ecolab
ECL
$75.6B
| $10.1M | 1.59% |
+118,156
| New | +$9.97M |
|
21
3M
MMM
$89B
| $9.74M | 1.54% |
+106,538
| New | +$9.67M |
|
|
SLH
22
DELISTED
SOLERA HOLDINGS, INC. COM
SLH
| $9.51M | 1.5% |
+170,917
| New | +$9.43M |
|
23
Idexx Laboratories
IDXX
$42.9B
| $9.25M | 1.46% |
+206,286
| New | +$9.01M |
|
|
DD
24
DELISTED
Du Pont De Nemours E I
DD
| $9.12M | 1.44% |
+182,881
| New | +$9.23M |
|
25
Watsco Inc
WSO
$14.9B
| $9.07M | 1.43% |
+108,093
| New | +$9.13M |
|
Similar funds
EGA
GM
SAM
LGP
NSLI
JFGIW
TMAM
MC
Howland Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Howland Capital Management, which disclosed 136 positions worth $633M. Its ten largest holdings account for 24% of the portfolio.
Its largest position is Edwards Lifesciences: 1,939,026 shares worth $8.55M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, followed by Technology and Industrials.
- Howland Capital Management's largest Q2 2013 buy was Edwards Lifesciences: 1,939,026 shares worth $8.55M.
- Howland Capital Management's ten largest holdings make up 24% of its $633M portfolio in Q2 2013.
- Howland Capital Management disclosed 136 positions in Q2 2013, its first 13F filing on record.
Based on Howland Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.